Search Within

Meghan Caitlin Thompson

Formats
  1. Meeting Abstract (27)
  2. Journal Article (10)
  3. Research Letter (8)
  4. Review (8)
  5. Editorial (2)
  6. Guidelines (1)
Groups
  1. GME, Medicine (56)
  2. Graduate Medical Education (56)
  3. Hematology-Oncology Fellows (56)
  4. Department of Medicine (45)
  5. Hematologic Malignancies, Division of (45)
  6. Adult Leukemia (39)

More Groups

People
  1. Lindsey Roeker (37)
  2. Anthony Mato (30)
  3. Andrew Zelenetz (17)
  4. Mark Geyer (10)
  5. Maria Palomba (9)
  6. Omar Abdel-Wahab (9)

More People

Years
  1. 2025 (8)
  2. 2024 (12)
  3. 2023 (10)
  4. 2022 (9)
  5. 2021 (12)
  6. 2020 (5)
Publications
  1. Blood (25)
  2. American Journal of Hematology (3)
  3. Blood Advances (3)
  4. British Journal of Haematology (3)
  5. Haematologica (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. John Wiley & Sons (4)
  3. Nature Publishing Group (4)
  4. Ferrata Storti Foundation (3)
  5. Wiley Blackwell (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimal residual disease (MRD)-adapted duration of front-line venetoclax and obinutuzumab treatment for fit patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Mato, A. R.; Zelenetz, A. D.; Park, J. H.; Geyer, M. B.; Derkach, A.; Nemirovsky, D.; Islam, P.; Falchi, L.; Palomba, M. L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Preliminary efficacy and safety of the Bruton tyrosine kinase degrader BGB-16673 in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase 1 CaDAnCe-101 study
    Meeting Abstract

    Thompson, M. C.; Parrondo, R. D.; Frustaci, A. M.; Allan, J. N.; Ghia, P.; Mocanu, I.; Tam, C. S.; Trotman, J.; Ahn, I. E.; Stilgenbauer, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Epcoritamab monotherapy in patients (pts) with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL): Results from CLL expansion and optimization cohorts of EPCORE CLL-1
    Meeting Abstract

    Danilov, A.; Fakhri, B.; Awan, F. T.; Bentzen, H. H.; Eradat, H. A.; Niemann, C. U.; Offner, F.; Poulsen, C. B.; Hoeyer, T.; Bellido, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment outcomes of patients treated with venetoclax-obinutuzumab therapy vs BTKi therapies in 1L CLL: An international real-world study
    Meeting Abstract

    Lamanna, N.; Brown, J. R.; Ujjani, C. S.; Eyre, T. A.; Manzoor, B.; Ghosh, N.; Roeker, L.; Davids, M. S.; Coombs, C. C.; Skarbnik, A. P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax
    Journal Article

    Valtis, Y. K.; Nemirovsky, D.; Derkach, A.; Sharan, S.; Kabel, C.; Ortiz, R.; Thompson, M. C.; Roeker, L. E.; Geyer, M. B.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
    Review

    Stanchina, M. D.; Montoya, S.; Danilov, A. V.; Castillo, J. J.; Alencar, A. J.; Chavez, J. C.; Cheah, C. Y.; Chiattone, C.; Wang, Y.; Thompson, M.; more...
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 2.2024
    Guidelines

    Wierda, W. G.; Brown, J.; Abramson, J. S.; Awan, F.; Bilgrami, S. F.; Bociek, G.; Brander, D.; Cortese, M.; Cripe, L.; Davis, R. S.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia
    Journal Article

    Kumar, J.; Ewalt, M. D.; Zhang, Y.; Yao, J.; Thompson, M. C.; Dogan, A.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save